TETRACYCLINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Tetracycline Hydrochloride patents expire, and what generic alternatives are available?
Tetracycline Hydrochloride is a drug marketed by Abbott, Amneal Pharms Ny, Ani Pharms, Aurobindo Pharma Usa, Breckenridge, Chartwell Tetra, Elkins Sinn, Ferrante, Heather, Hikma, Impax Labs, Ivax Sub Teva Pharms, Mast Mm, Purepac Pharm, Pvt Form, Roxane, Strides Pharma, Sun Pharm Industries, Superpharm, Valeant Pharm Intl, Warner Chilcott, Watson Labs, Wyeth Ayerst, Alpharma Us Pharms, and Proter. and is included in twenty-nine NDAs.
The generic ingredient in TETRACYCLINE HYDROCHLORIDE is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tetracycline Hydrochloride
A generic version of TETRACYCLINE HYDROCHLORIDE was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TETRACYCLINE HYDROCHLORIDE?
- What are the global sales for TETRACYCLINE HYDROCHLORIDE?
- What is Average Wholesale Price for TETRACYCLINE HYDROCHLORIDE?
Summary for TETRACYCLINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 25 |
| NDAs: | 29 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Clinical Trials: | 227 |
| What excipients (inactive ingredients) are in TETRACYCLINE HYDROCHLORIDE? | TETRACYCLINE HYDROCHLORIDE excipients list |
| DailyMed Link: | TETRACYCLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TETRACYCLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit | Phase 2/Phase 3 |
| Mahidol Oxford Tropical Medicine Research Unit | Phase 2/Phase 3 |
| Universidade Federal do Para | Phase 3 |
Pharmacology for TETRACYCLINE HYDROCHLORIDE
| Drug Class | Tetracycline-class Antimicrobial |
Anatomical Therapeutic Chemical (ATC) Classes for TETRACYCLINE HYDROCHLORIDE
US Patents and Regulatory Information for TETRACYCLINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | TETRACYCLINE HYDROCHLORIDE | tetracycline hydrochloride | CAPSULE;ORAL | 062103-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | TETRACYCLINE HYDROCHLORIDE | tetracycline hydrochloride | CAPSULE;ORAL | 060736-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ferrante | TETRACYCLINE HYDROCHLORIDE | tetracycline hydrochloride | SUSPENSION;ORAL | 060174-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
